Patrick John Finn
COO, President at Twist Bioscience Corp (TWST)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $22.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 5SEC | TWSTTwist Bioscience Corp | Sell | 25,714185,088 held (−12%) | $188.88 | $4.9M | -15.4% |
| Aug 25SEC | TWSTTwist Bioscience Corp | Sell | 4,046210,802 held (−2%) | $139.07 | $563K | +14.9% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 33,354259,679 held (−11%) | $115.90 | $3.9M | +37.9% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 10,420249,259 held (−4%) | $116.82 | $1.2M | +36.8% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 8,868240,391 held (−4%) | $117.70 | $1.0M | +35.8% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 4,500235,891 held (−2%) | $119.04 | $536K | +34.2% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 12,917222,974 held (−5%) | $119.86 | $1.5M | +33.3% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 6,296216,678 held (−3%) | $121.01 | $762K | +32.0% |
| Aug 20SEC | TWSTTwist Bioscience Corp | Sell Plan | 2,000214,678 held (−1%) | $122.58 | $245K | +30.3% |
| Aug 5SEC | TWSTTwist Bioscience Corp | Sell | 2,888269,678 held (−1%) | $85.32 | $246K | +87.3% |
| Jul 27SEC | TWSTTwist Bioscience Corp | Sell | 2,238272,566 held (−1%) | $93.89 | $210K | +70.2% |
| May 26SEC | TWSTTwist Bioscience Corp | Sell | 4,160274,804 held (−1%) | $53.26 | $222K | +200.0% |
| May 6SEC | TWSTTwist Bioscience Corp | Sell | 2,844278,964 held (−1%) | $57.15 | $163K | +179.6% |
| Apr 27SEC | TWSTTwist Bioscience Corp | Sell | 2,321281,808 held (−1%) | $60.76 | $141K | +163.0% |
| Feb 25SEC | TWSTTwist Bioscience Corp | Sell | 4,294284,129 held (−1%) | $46.71 | $201K | +242.1% |
| Feb 19SEC | TWSTTwist Bioscience Corp | Sell Plan | 21,858334,897 held (−6%) | $50.32 | $1.1M | +217.5% |
| Feb 19SEC | TWSTTwist Bioscience Corp | Sell Plan | 16,616318,281 held (−5%) | $51.42 | $854K | +210.7% |
| Feb 19SEC | TWSTTwist Bioscience Corp | Sell Plan | 26,952291,329 held (−8%) | $52.69 | $1.4M | +203.2% |
| Feb 19SEC | TWSTTwist Bioscience Corp | Sell Plan | 3,541287,788 held (−1%) | $53.11 | $188K | +200.8% |
| Feb 17SEC | TWSTTwist Bioscience Corp | Sell Plan | 3,500306,788 held (−1%) | $50.23 | $176K | +218.1% |
| Feb 17SEC | TWSTTwist Bioscience Corp | Sell Plan | 1,750306,250 held (−1%) | $50.04 | $88K | +219.3% |
| Feb 5SEC | TWSTTwist Bioscience Corp | Sell | 2,705307,788 held (−1%) | $46.58 | $126K | +243.0% |
| Jan 27SEC | TWSTTwist Bioscience Corp | Sell | 2,390310,493 held (−1%) | $44.91 | $107K | +255.8% |
| Jan 15SEC | TWSTTwist Bioscience Corp | Sell Plan | 23,279312,883 held (−7%) | $40.00 | $931K | +299.4% |
| Nov 25SEC | TWSTTwist Bioscience Corp | Sell | 1,776332,883 held (−1%) | $26.50 | $47K | +502.9% |
| Nov 5SEC | TWSTTwist Bioscience Corp | Sell | 2,755265,919 held (−1%) | $32.08 | $88K | +398.1% |
| Nov 3SEC | TWSTTwist Bioscience Corp | Sell | 17,606268,674 held (−6%) | $31.44 | $554K | +408.2% |
| Oct 27SEC | TWSTTwist Bioscience Corp | Sell | 2,240206,495 held (−1%) | $30.88 | $69K | +417.4% |
| Oct 8SEC | TWSTTwist Bioscience Corp | Sell | 23,747208,735 held (−10%) | $32.19 | $764K | +396.4% |
| Oct 6SEC | TWSTTwist Bioscience Corp | Sell | 206232,482 held (−0%) | $29.16 | $6K | +447.9% |
- Sell
COO, President Patrick John Finn sold $3.9M of TWST at $115.90 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Patrick John Finn sold $1.2M of TWST at $116.82 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Patrick John Finn sold $1.0M of TWST at $117.70 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Patrick John Finn sold $536K of TWST at $119.04 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Patrick John Finn sold $1.5M of TWST at $119.86 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Patrick John Finn sold $762K of TWST at $121.01 — pre-scheduled 10b5-1 plan sale.